Danaher Corporation vs Johnson & Johnson
DHR vs JNJ — side-by-side comparison from reported financials. DHR leads 2, JNJ leads 9 of 11 comparable metrics.
Danaher Corporation
DHR · Healthcare
$219.81+1.08%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | DHR | JNJ |
|---|---|---|
| Price | $219.81 | $261.79 |
| Market cap | $155B | $631B |
| Revenue (TTM) | $25.1B | $97.9B |
| Revenue growth | -2.7% | +5.6% |
| Net margin | 15.9% | 21.5% |
| Free cash flow | $5.47B | $22.2B |
| Net cash (debt) | ($13.8B) | ($27.8B) |
| 1-year price return | +7.5% | +37.0% |
| P/E | 38.6 | 29.9 |
| P/E vs own history (cheap-side %) | 38% | 16% |
| Dividend yield | 0.62% | 2.00% |
| Return on equity | 8% | 26% |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 60,000 | 140,800 |
Full résumé-style profiles: DHR CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.